PlainPharmaWatch

CMS Open Payments · Program Year 2024

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc. reported $6,136,179.72 in payments to 3,134 physicians and teaching hospitals across 3,984 transactions.

See the rankings → How this is sourced
$6.1M
Total payments
3,984
Transactions
3,134
Recipients
+$229.8K
General Payments vs PY2023

Agios Pharmaceuticals, Inc. reported $6,136,179.72 in payments to 3,134 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #238 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $2.0K per recipient across 8 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Agios Pharmaceuticals, Inc. pairs top-quartile payment volume with a moderately concentrated payment pattern.

#238
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
8
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Agios Pharmaceuticals, Inc.'s CMS-reported General Payments increased by $229.8K (+17.9%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: AGIOS PHARMACEUTICALS, INC.PY2023: AGIOS PHARMACEUTICALS, INC.PY2024: Agios Pharmaceuticals, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.3MPY2024$1.5M
PY2023
$1,282,842.32
PY2024
$1,512,676.91

How Agios Pharmaceuticals, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Agios Pharmaceuticals, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$6,136,180 Top 12% higher than 88% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Agios Pharmaceuticals, Inc.

$6,136,179.72: that is what Agios Pharmaceuticals, Inc. reported in payments to 3,134 physicians and teaching hospitals during Program Year 2024, spread across 3,984 transactions ($1.5K per transaction, $2.0K per recipient). The company sits at rank #238 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

16 transactions worth $760.2K make "Compensation for Services Other Than Consulting" the top general-payment category in the 8-category breakdown below, 12.4% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 8 types of general payments, Agios Pharmaceuticals, Inc.'s largest category was "Compensation for Services Other Than Consulting" at $760.2K - 12.4% of the company's reported total.

How Agios Pharmaceuticals, Inc. divides its payments

General-payment categories, ordered by reported total

1. Compensation for Services…$760.2K2. Consulting Fee$309.5K3. Honoraria$166.3K4. Space Rental or Facility …$104.5K5. Food and Beverage$90.4K6. Grant$45.0K7. Travel and Lodging$34.1K8. Education$2.7K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $760.2K 16
Consulting Fee $309.5K 88
Honoraria $166.3K 72
Space Rental or Facility Fees $104.5K 16
Food and Beverage $90.4K 2,711
Grant $45.0K 2
Travel and Lodging $34.1K 75
Education $2.7K 154

Recipient Concentration in General Payments

The five largest recipient relationships account for $957,805.92 (63.3%) of $1,512,676.91 in this company's General Payments records across 2,215 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Agios Pharmaceuticals, Inc.

The five named recipients with the highest reported General Payments from this company

David Scadden$412.6KDavid Schenkein$403.1KScripps Mercy Hospital$49.8KMatthew Vander Heiden$48.0KSherif Badawy$44.3K
  1. 1

    David Scadden

    $412,619.67 across 8 reported transactions

  2. 2

    David Schenkein

    $403,125.00 across 5 reported transactions

  3. 3

    Scripps Mercy Hospital

    $49,750.00 across 3 reported transactions

  4. 4

    Matthew Vander Heiden

    $48,000.00 across 11 reported transactions

  5. 5

    Sherif Badawy

    $44,311.25 across 28 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $1.5K. Average per recipient: $2.0K.

Total Amount

$6,136,179.72

Avg per Transaction

$1.5K

Avg per Recipient

$2.0K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Agios Pharmaceuticals, Inc. Share

0.0%

#238 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Agios Pharmaceuticals, Inc.

Roche Products Limited

$6.1M 124 recipients

Sobi, Inc

$6.1M 16,390 recipients

Davol Inc.

$6.2M 12,178 recipients

Tandem Diabetes Care, Inc.

$6.1M 9,526 recipients

CooperVision Inc.

$6.2M 29,989 recipients

Dental Buying Power LLC

$6.2M 0 recipients

Frequently Asked Questions

How much did Agios Pharmaceuticals, Inc. pay to physicians and hospitals in 2024? ▾
Agios Pharmaceuticals, Inc. made $6,136,179.72 in payments to physicians and hospitals in Program Year 2024, across 3,984 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Agios Pharmaceuticals, Inc.? ▾
Averaging $2.0K per recipient, Agios Pharmaceuticals, Inc.'s 2024 payments reached 3,134 physicians and teaching hospitals.
What types of payments did Agios Pharmaceuticals, Inc. make? ▾
8 categories of general payment make up Agios Pharmaceuticals, Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Compensation for Services Other Than Consulting" at $760.2K, representing 12.4% of the company's reported total.
How does Agios Pharmaceuticals, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Agios Pharmaceuticals, Inc. sits at #238 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Agios Pharmaceuticals, Inc.? ▾
The average transaction from Agios Pharmaceuticals, Inc. was $1.5K in 2024. The company made 3,984 total transactions to 3,134 recipients.
Where does the payment data for Agios Pharmaceuticals, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Agios Pharmaceuticals, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.